JP2022539329A5 - - Google Patents

Info

Publication number
JP2022539329A5
JP2022539329A5 JP2021576479A JP2021576479A JP2022539329A5 JP 2022539329 A5 JP2022539329 A5 JP 2022539329A5 JP 2021576479 A JP2021576479 A JP 2021576479A JP 2021576479 A JP2021576479 A JP 2021576479A JP 2022539329 A5 JP2022539329 A5 JP 2022539329A5
Authority
JP
Japan
Application number
JP2021576479A
Other languages
Japanese (ja)
Other versions
JP2022539329A (ja
JP7615061B2 (ja
JPWO2020259528A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2020/097881 external-priority patent/WO2020259528A1/zh
Publication of JP2022539329A publication Critical patent/JP2022539329A/ja
Publication of JP2022539329A5 publication Critical patent/JP2022539329A5/ja
Publication of JPWO2020259528A5 publication Critical patent/JPWO2020259528A5/ja
Application granted granted Critical
Publication of JP7615061B2 publication Critical patent/JP7615061B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021576479A 2019-06-25 2020-06-24 特発性肺線維症を治療する方法 Active JP7615061B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2019092675 2019-06-25
CNPCT/CN2019/092675 2019-06-25
PCT/CN2020/097881 WO2020259528A1 (zh) 2019-06-25 2020-06-24 治疗特发性肺纤维化的方法

Publications (4)

Publication Number Publication Date
JP2022539329A JP2022539329A (ja) 2022-09-08
JP2022539329A5 true JP2022539329A5 (https=) 2023-06-29
JPWO2020259528A5 JPWO2020259528A5 (https=) 2023-06-29
JP7615061B2 JP7615061B2 (ja) 2025-01-16

Family

ID=74061495

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021576479A Active JP7615061B2 (ja) 2019-06-25 2020-06-24 特発性肺線維症を治療する方法

Country Status (11)

Country Link
US (1) US12582653B2 (https=)
EP (1) EP3992183A4 (https=)
JP (1) JP7615061B2 (https=)
KR (1) KR20220029681A (https=)
CN (2) CN114026072A (https=)
AU (1) AU2020305979B2 (https=)
BR (1) BR112021026214A2 (https=)
CA (1) CA3144113A1 (https=)
IL (1) IL289192A (https=)
TW (1) TWI804743B (https=)
WO (1) WO2020259528A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023539276A (ja) * 2020-08-31 2023-09-13 ベイジン タイド ファーマシューティカル カンパニー リミテッド Rho関連タンパク質キナーゼ阻害剤の塩、その固体形態、その調製方法およびその使用
CA3209240A1 (en) * 2021-02-22 2022-08-25 Samuel D. Waksal Rock2 inhibitor for the treatment of viral infection
NO346587B1 (en) * 2021-06-02 2022-10-17 Axichem Ab Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis
TW202327608A (zh) * 2021-09-17 2023-07-16 北京泰德製藥股份有限公司 治療病毒感染的方法
IL311447A (en) * 2021-09-18 2024-05-01 Beijing Tide Pharmaceutical Co Ltd A solid form of a Rho-linked protein kinase inhibitor or a solvate thereof, a method of preparation and use thereof
KR20240095429A (ko) * 2021-11-16 2024-06-25 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 Rock2 억제제의 나노결정 제제 및 이의 제조방법
WO2023134688A1 (zh) * 2022-01-13 2023-07-20 武汉朗来科技发展有限公司 一种rock抑制剂的盐及盐的晶型、组合物和药物用途
EP4591863A1 (en) * 2022-10-13 2025-07-30 Beijing Tide Pharmaceutical Co., Ltd. Method for treating pneumoconiosis
WO2025017499A1 (en) 2023-07-17 2025-01-23 Graviton Bioscience Bv Formulations and uses of rock2 inhibitors for als
IL325831A (en) 2023-07-17 2026-03-01 Graviton Bioscience Bv ROCK2 inhibitor formulations for central nervous system disorders
WO2025069008A1 (en) 2023-09-28 2025-04-03 Graviton Bioscience Bv Therapy for treating type 1 diabetes using rock2 and dyrk1 inhibitors
WO2025069009A1 (en) 2023-09-29 2025-04-03 Graviton Bioscience Bv Rock2 inhibitors in the treatment of obesity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016138335A1 (en) * 2015-02-27 2016-09-01 Lycera Corporation Indazolyl thiadiazolamines and related compounds for inhibition of rho-associated protein kinase and the treatment of disease
AR110401A1 (es) 2016-12-21 2019-03-27 Chiesi Farm Spa Derivados dihidropirimidina bicíclica-carboxamida como inhibidores de rho-quinasa
CN110582489B (zh) * 2017-06-30 2023-10-27 北京泰德制药股份有限公司 Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
WO2019000682A1 (zh) * 2017-06-30 2019-01-03 北京泰德制药股份有限公司 Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途

Similar Documents

Publication Publication Date Title
JP2022539329A5 (https=)
CN305775714S (https=)
CN305738962S (https=)
CN305544725S (https=)
CN305585913S (https=)
CN305589426S (https=)
CN305593432S (https=)
CN305616168S (https=)
CN305616330S (https=)
CN305643601S (https=)
CN305644016S (https=)
CN305645107S (https=)
CN305646899S (https=)
CN305649135S (https=)
CN305650692S (https=)
CN305669543S (https=)
CN305670363S (https=)
CN305671976S (https=)
CN305672803S (https=)
CN305674957S (https=)
CN305675806S (https=)
CN305711803S (https=)
CN305717472S (https=)
CN305717633S (https=)
CN305719413S (https=)